UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007524
Receipt number R000008886
Scientific Title Clinical usefulness of measuring tartrate-resistant acid phosphatase 5b in predicting bone turnover in peritoneal dialysis patients
Date of disclosure of the study information 2012/03/19
Last modified on 2012/11/12 15:01:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical usefulness of measuring tartrate-resistant acid phosphatase 5b in predicting bone turnover in peritoneal dialysis patients

Acronym

Clinical Usefulness of measurement of TRACP5b in PD patients

Scientific Title

Clinical usefulness of measuring tartrate-resistant acid phosphatase 5b in predicting bone turnover in peritoneal dialysis patients

Scientific Title:Acronym

Clinical Usefulness of measurement of TRACP5b in PD patients

Region

Japan


Condition

Condition

Endstage renal failure patients on peritoneal dialysis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the clinical usefulness of measuring serum TRACP5b in peritoneal dialysis patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To assess the relationship between TRACP5b and other established bone turnover markers

Key secondary outcomes

To determine the effect of residual kidney function and peritoneal dialysis treatment of bone markers includin TRACP5b


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who receives peritoneal dialysis treatment at Kyushu University Hospital

Key exclusion criteria

Patients who did not give written informed consent

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiko Tsuruya

Organization

Kyushu University

Division name

Department of Integrated Thearpy for Chronic Kidney Disease, Graduate School of Medical Sciences

Zip code


Address

3-1-1Maidashi, Higashi-Ku, Fukuoka

TEL

092-642-5843

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shunsuke Yamada

Organization

Kyushu University

Division name

Department of Medicine and Clinical Science, Graduate School of Medical Sciences

Zip code


Address

3-1-1Maidashi, Higashi-Ku, Fukuoka

TEL

092-642-5256

Homepage URL

http://www.c-shop.net/kyudai_kcu/index.html

Email

ana65641@nifty.com


Sponsor or person

Institute

Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 19 Day


Related information

URL releasing protocol

http://www.c-shop.net/kyudai_kcu/index.html

Publication of results

Published


Result

URL related to results and publications

http://www.c-shop.net/kyudai_kcu/index.html

Number of participants that the trial has enrolled


Results

Serum Tartrate resistant acid phosphatase 5b shows linear relationship with other bone metabolic markers including NTX, PTH, and BAP. Serum TRACP5b was not influenced by residual renal function.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 18 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2012 Year 04 Month 01 Day

Date of closure to data entry

2012 Year 05 Month 01 Day

Date trial data considered complete

2012 Year 05 Month 01 Day

Date analysis concluded

2012 Year 06 Month 01 Day


Other

Other related information

Now under resitration


Management information

Registered date

2012 Year 03 Month 18 Day

Last modified on

2012 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008886


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name